EFDID: 507732EFD: View Filing

Issuer: Perspective Therapeutics, Inc. (0000728387) - D

Accession: 0001437749-24-001858 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000728387
  • Entity Name:
    Perspective Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    2401 Elliott Avenue
    Suite 320
    Seattle, WA 98121
  • Persons:
    Related Persons 8
    Johan (Thijs) Spoor
    Executive Officer, Director
    Lori Woods
    Director
    Frank Morich
    Director
    Heidi Henson
    Director
    Robert Williamson III
    Director
    Jonathan Hunt
    Executive Officer
    Markus Puhlmann
    Executive Officer
    Mark Austin
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    01/22/2024
  • First Sale Date:
    01/08/2024
  • Offering Amount:
    $20,846,671
  • Amount Sold:
    $20,846,671
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Based on 56,342,355 shares of common stock at $0.37 per share.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Perspective Therapeutics, Inc./s/ Johan (Thijs) SpoorJohan (Thijs) SpoorChief Executive Officer2024-01-22